J
Jan Budczies
Researcher at University Hospital Heidelberg
Publications - 185
Citations - 16222
Jan Budczies is an academic researcher from University Hospital Heidelberg. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 48, co-authored 166 publications receiving 12762 citations. Previous affiliations of Jan Budczies include German Cancer Research Center & Humboldt University of Berlin.
Papers
More filters
Journal ArticleDOI
Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.
H. R. Goldschmid,Klaus Kluck,Markus Ball,Martina Kirchner,Michael Allgäuer,Hauke Winter,Felix J.F. Herth,Claus Peter Heussel,Soni Savai Pullamsetti,Rajkumar Savai,Peter Schirmacher,Solange Peters,Mike Thomas,Petros Christopoulos,Jan Budczies,Albrecht Stenzinger,Daniel Kazdal +16 more
TL;DR: In this paper , the authors performed multi-region sampling (2-4 samples per tumor; total of 55 samples) from a cohort of 19 untreated stage IA-IIIB lung adenocarcinomas (n = 11 KRAS mutant, n = 1 ERBB2 mutant and n = 7 KRAS wildtype).
Book ChapterDOI
Introduction on Genome-wide Expression Profiling from Formalin-Fixed Paraffin-Embedded Tissues Using Microarrays
TL;DR: New protocols for RNA processing of FFPE specimens revealed similar results as compared to the frozen tissue samples, which appears to be surprising given the fact that formalin fixation produces significant chemical modification of the RNA that depends on fixation conditions and times.
Journal ArticleDOI
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis
Eva Romanovsky,Klaus Kluck,Iordanis Ourailidis,Michael Menzel,Susanne Beck,Markus Ball,Daniel Kazdal,Petros Christopoulos,Peter Schirmacher,Thorsten Stiewe,Albrecht Stenzinger,Jan Budczies +11 more
TL;DR: In this paper , a comprehensive mRNA expression analysis in 24 cancer types of TCGA was performed to extract a consensus expression signature shared across TP53 mutation types and cancer types, and differential gene expression patterns between tumors harboring different TP53 mutations such as loss of function, gain of function or dominant negative mutations, and cancer-type specific patterns of gene expression and immune infiltration.
Journal ArticleDOI
Von der Paneldiagnostik zu umfassenden genomischen Analysen
Jonas Leichsenring,Daniel Kazdal,Carolin Ploeger,Michael Allgäuer,Volker Endris,Anna-Lena Volckmar,Olaf Neumann,Martina Kirchner,Roland Penzel,Eugen Rempel,Jan Budczies,Peter Schirmacher,Stefan Fröhling,A. Stenzinger +13 more
TL;DR: Key aspects and applications of each method are summarized and discussed, and all approved predictive biomarkers and molecular targets, including gene fusions and copy number alterations, can be identified depending on panel design and method applied.
Journal ArticleDOI
Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling".
Scarlet F. Brockmöller,Elmar Bucher,Berit Maria Müller,Jan Budczies,Mika Hilvo,Julian L. Griffin,Matej Orešič,Olli Kallioniemi,Kristiina Iljin,Sibylle Loibl,Silvia Darb-Esfahani,Bruno Valentin Sinn,Frederick Klauschen,Judith Prinzler,Nikola Bangemann,Fakher Ismaeel,Oliver Fiehn,Manfred Dietel,Carsten Denkert +18 more
TL;DR: The Altmetric Attention Score as discussed by the authors is a quantitative measure of the attention that a research article has received online, and it is calculated using the Alt-Metric Attention Index (AUI) metric.